Total Funding
74
66
Total FundingPost-IPO Equity raised
Growth Score
-14 pts
Heat Score
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
184708
Grace Therapeutics is an emerging biopharmaceutical company.
- Prashant Kohli: Vice President, Commercial Operations
- Pierre Lemieux: COO
About the Company
Grace Therapeutics is an emerging biopharmaceutical company dedicated to the research, development, and commercialization of innovative proprietary active pharmaceutical ingredients (API) for managing cardiometabolic disorders, from prevention to treatment, through a novel superior approach to lipid regulation.
